Bath salts ingestion: Diagnosis and treatment of substance-induced disorders

Journal for Nurse Practitioners

Volumn 9, Issue 7, 2013, Pages 403-410

  Jordan, Julia Tegarden ^a   Harrison, Barbara E ^b  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

Author keywords

Bath salts; Methylenedioxypyrovalerone; Substance induced disorders

Indexed keywords

EID: 84879576242     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2013.04.018     Document Type: Article

References (28)

1. Marder J. Bath salts: the drug that never lets go. Accessed September 21,2012. http://www.pbs.org/newshour/multimedia/bath-salts/.
2. McGraw M.M. Is your patient high on "bath salts"?. Nursing 2012, 42:26-32.
3. Drug Enforcement Agency. Accessed April 22,2013. http://www.regulations.gov/#!documentDetail;D=DEA_FRDOC_0001-0103.
4. Winder G.S., Stern N., Hosanager A. Are "bath salts" the next generation of stimulant abuse?. JSubst Abuse Treat 2013, 44:42-45.
5. Bronstein A, Spyker DA, Cantilena LR, etal. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Accessed May 13,2013. http://informahealthcare.com/doi/pdf/10.3109/15563650.2011.635149.
6. European Monitoring Centre for Drugs and Drug Addiction Web site. Accessed April 22,2013. http://www.emcdda.europa.eu.
7. Kelly J.P. Cathinones derivatives: a review of their chemistry, pharmacology, and toxicology. Drug Test Analysis 2011, 3:439-453.
8. Baumann M.H., Partilla J.S., Lehner K.R., et al. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive "bath salts" products. Neuropsychopharmacology 2013, 38(4):552-562.
9. Ross E.A., Reisfield G.M., Watson M.C., Chronister C.W., Goldberger B.A. Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. Am J Med 2012, 125:854-858.
10. O'Malley P. The worldwide designer drug craze - bath salts behind the counter to get high: update for the clinical nurse specialist. Clin Nurs Spec 2011, 25:224-225.
11. Cameron K.N., Kolanos R., Solis E., Glennon R.A., DeFelice L.J. Bath salts: components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 2013, 168(7):1750-1757.
12. Rodrigue-Menchaca A.A., Solis E., Cameron K., DeFelice L.J. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis. Br J Pharmacol 2012, 165:2749-2757.
13. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. JMed Toxicol 2012, 8:33-42.
14. Diagnostic and Statistical Manual of Mental Disorders. 5th ed 2013, American Psychiatric Association, American Psychiatric Association, Washington, DC.
15. Ghandour A., Saab R., Mehr D.R. Detecting and treating delirium-key interventions you may be missing. JFam Pract 2011, 60:726-734.
16. Olsen Q.R., Regis J.T. Delirious deficiency. Lancet 2010, 376:1362.
17. Sahoo M.K., Avasthi A., Singh P. Negative symptoms presenting as neuropsychiatric manifestation of vitamin B12 deficiency. Indian J Psychiatry 2011, 53:370-371.
18. Gopinath P., Mihai R. Hyperparathyroidism. Endocrine Surg 2011, 29:451-458.
19. Iglesias P., Devora O., Garcia J., Tajada P., Garcia-Arevalo C., Diez J.J. Severe hyperthyroidism: aetiology, clinical features and treatment outcome. Clin Endocrinol 2009, 72:551-557.
20. Gerona R.R., Wu A.H.B. Bath salts: chemistry, metabolism and analysis. Clin Lab Med 2012, 32:415-427.
21. Leoffler G., Hurst D., Penn A., Yung K. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. armed forces. Mil Med 2012, 177:1041-1048.
22. Glenn M.B. Sudden cardiac death and stroke with the use of antipsychotic medications: implications for clinicians treating individuals with traumatic brain injury. JHead Trauma Rehabil 2010, 25:68-70.
23. Rosenbaum C.D., Carreiro S.P., Babu K.M. Here today, gone tomorrow. . .and back again? A review of herbal marijuana alternative (K2, Spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. JMed Toxicol 2012, 8:15-32.
24. Prosser J.M., Nelson L.S. The toxicology of bath salts: a review of synthetic cathinones. JMed Toxicol 2012, 8:33-42.
25. ePocrates (Haldol Lactate) [computer program]. ePocrates, Inc; Ver 5.1.1/Apr 22, 2013.
26. Grover S., Shah R. Distress due to delirium experience. Gen Hosp Psychiatry 2011, 33:637-639.
27. Penders T.M., Gestring R. Hallucinatory delirium following use of MDPV: bath salts. Gen Hosp Psychiatry 2011, 33:525-526.
28. Adebamiro A., Perazella M.A. Recurrent acute kidney injury following bath salts intoxication. Am J Kidney Dis 2012, 59:273-275.